3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Lung Neoplasms
4
Stomach Neoplasms
3
Uterine Cervical Neoplasms
1
Smoking
1
Recurrence
1
Pulmonary Disease, Chronic Obstructive
1
Platelet Glycoprotein IV Deficiency
1
Pediatric Brain Tumor
1
Pancreatic Cyst
1
Ovarian Neoplasms
1
Osteosarcoma
1
Neuroendocrine Tumors
1
Neoplasms
1
Melanoma
1
Lymphoma
1
Locally Advanced Pancreatic Cancer
1
Gastrointestinal Neoplasms
1
Fatty Liver
1
Cysts
1
Colorectal Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Anus Neoplasms
1
Adenocarcinoma
1
Interventions
Oxaliplatin
10
pembrolizumab
8
Fluorouracil
8
Leucovorin
7
Paclitaxel
5
Gemcitabine
5
Docetaxel
5
Capecitabine
5
Cyclophosphamide
4
Blood Specimen Collection
4
zolbetuximab
3
fludarabine
3
darolutamide
3
cemiplimab
3
Trastuzumab
3
Taxes
3
Ramucirumab
3
Radiotherapy
3
Radiosurgery
3
Irinotecan
3
trastuzumab deruxtecan
2
enzalutamide
2
durvalumab
2
Standard of Care
2
Nivolumab
2
Folfox protocol
2
Dexamethasone
2
Cisplatin
2
130-nm albumin-bound paclitaxel
2
tucatinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Adenocarcinoma
×
Tomography, X-Ray Computed
×
Clear all
NCT06867172
2025-03-10
SPACE
Carol Davila University of Medicine and Pharmacy
Recruiting
66 enrolled